Is Vyome Holdings struggling financially?

Yes, by its own account. Vyome Holdings told the SEC on 31 Mar 2026, in Form DEF 14A, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed Mar 2026

30/100

Fragile

Sector: Biotech/Pharma
Market cap: $15.8M
Source filing: DEF 14A 31 Mar 2026
Balance sheet: 30 Jun 2026

Cash runway

10months

If the burn speeds up

Empty by Apr 2027
15months

If it eases off

Empty by Sep 2027

Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$7.9M

Cash burned over the last 12 months

$7.5M

What Vyome Holdings told the SEC

…or modified as to uncertainty, audit scope, or accounting principles, except that such reports contained a separate emphasis of matter paragraph related to substantial doubt about the Company’s ability to continue as a going concern. During the fiscal year ended December 31, 2024 and subsequent interim period through August 18, 2025, there were no disagreements with Haskell on any matter of accounting principles…

VYOME HOLDINGS, INC., Form DEF 14A, filed 31 Mar 2026.

Read the filing on SEC.gov

What this means

Not a bankruptcy filing, and not a prediction.
It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

994.7% share-count increase The company issued stock. Each share now owns 90.9% less of the business than a year ago, before any change in the price.
Cash burn is increasing It is spending 274% more cash per year than it was, so the runway above shortens even if nothing else changes.

Cash runway

The runway math

What Vyome Holdings told the SEC

What this means

What else the numbers show

Other Biotech/Pharma companies that filed the doubt